BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ahluwalia P, Ahluwalia M, Vaibhav K, Mondal A, Sahajpal N, Islam S, Fulzele S, Kota V, Dhandapani K, Baban B, Rojiani AM, Kolhe R. Infections of the lung: a predictive, preventive and personalized perspective through the lens of evolution, the emergence of SARS-CoV-2 and its pathogenesis. EPMA J 2020;:1-21. [PMID: 33204369 DOI: 10.1007/s13167-020-00230-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 De Freitas VM, Chiloff DM, Bosso GG, Teixeira JOP, Hernandes ICG, Padilha MDP, Moura GC, De Andrade LGM, Mancuso F, Finamor FE, Serodio AMB, Arakaki JSO, Sartori MGF, Ferreira PRA, Rangel ÉB. A Machine Learning Model for Predicting Hospitalization in Patients with Respiratory Symptoms during the COVID-19 Pandemic. J Clin Med 2022;11:4574. [PMID: 35956189 DOI: 10.3390/jcm11154574] [Reference Citation Analysis]
2 Chawla S, Chawla S. Comparative Analysis of Susceptibility and Severity of COVID-19 in Countries from the Eastern and the Western World Till March '21. Microbiol Insights 2021;14:11786361211041367. [PMID: 34483666 DOI: 10.1177/11786361211041367] [Reference Citation Analysis]
3 Liskova A, Koklesova L, Samec M, Abdellatif B, Zhai K, Siddiqui M, Šudomová M, Hassan STS, Kudela E, Biringer K, Giordano FA, Büsselberg D, Golubnitschaja O, Kubatka P. Targeting phytoprotection in the COVID-19-induced lung damage and associated systemic effects-the evidence-based 3PM proposition to mitigate individual risks. EPMA J 2021;:1-23. [PMID: 34367380 DOI: 10.1007/s13167-021-00249-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wang LY, Cui JJ, OuYang QY, Zhan Y, Wang YM, Xu XY, Yu LL, Yin H, Wang Y, Luo CH, Guo CX, Yin JY. Complex analysis of the personalized pharmacotherapy in the management of COVID-19 patients and suggestions for applications of predictive, preventive, and personalized medicine attitude. EPMA J 2021;:1-18. [PMID: 34306260 DOI: 10.1007/s13167-021-00247-0] [Reference Citation Analysis]
5 Richter K, Kellner S, Hillemacher T, Golubnitschaja O. Sleep quality and COVID-19 outcomes: the evidence-based lessons in the framework of predictive, preventive and personalised (3P) medicine. EPMA J 2021;:1-21. [PMID: 34122671 DOI: 10.1007/s13167-021-00245-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
6 Ahluwalia P, Vaibhav K, Ahluwalia M, Mondal AK, Sahajpal N, Rojiani AM, Kolhe R. Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2. Front Immunol 2021;12:660019. [PMID: 34046033 DOI: 10.3389/fimmu.2021.660019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Tachalov VV, Orekhova LY, Kudryavtseva TV, Loboda ES, Pachkoriia MG, Berezkina IV, Golubnitschaja O. Making a complex dental care tailored to the person: population health in focus of predictive, preventive and personalised (3P) medical approach. EPMA J 2021;:1-12. [PMID: 33897916 DOI: 10.1007/s13167-021-00240-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Gutowski Ł, Gutowska K, Brożek A, Nowicki M, Formanowicz D. ABG Assistant-Towards an Understanding of Complex Acid-Base Disorders. J Clin Med 2021;10:1516. [PMID: 33916476 DOI: 10.3390/jcm10071516] [Reference Citation Analysis]
9 Skladany L, Koller T, Adamcova Selcanova S, Vnencakova J, Jancekova D, Durajova V, Laffers L, Svac J, Janickova K, Palkovič M, Kohout P, Golubnitschaja O. Challenging management of severe chronic disorders in acute pandemic situation: Chronic liver disease under COVID-19 pandemic as the proof-of-principle model to orchestrate the measures in 3PM context. EPMA J 2021;:1-14. [PMID: 33680218 DOI: 10.1007/s13167-021-00231-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
10 Mathew S, Faheem M, Hassain NA, Benslimane FM, Thani AAA, Zaraket H, Yassine HM. Platforms Exploited for SARS-CoV-2 Vaccine Development. Vaccines (Basel) 2020;9:11. [PMID: 33375677 DOI: 10.3390/vaccines9010011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]